Organigram Global Inc.

NASDAQ:OGI

Drug Manufacturers - Specialty & Generic

Healthcare
$0.68 -1.74%

-$0.02 today

Market cap
$95.40M
Beta
1.84
P/E (TTM)
-7.2
EPS (TTM)
-$0.19
52W Low $0.97High $2.24

Volume 0.62M

Average 0.67M

OGI Interest Expense

Cost of servicing the company's debt during the period.

Organigram Global Inc.NASDAQ: OGI

Interest Expense · Q2 FY2026 · quarter ended Mar 2026

Interest expense remains negative

Q2 FY2026 interest expense was CA$0, compared with CA$0 a year earlier. Trailing-twelve-month interest expense was CA$0.

Context

  • Interest expense amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 0 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly interest expense holds near CA$0 or moves back toward the trailing-twelve-month quarterly average of CA$0.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$0— QoQ
Last fiscal yearSep 2025
CA$0— YoY
LTMMar 2026
CA$0-100.0% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Interest Expense history

CAD · from the income statement

Latest · FY2025
0 CAD
Year-over-year change
—

Interest Expense vs competitors

How OGI compares with its peers on the latest reported figures

  • Peers report in different currencies, so interest expense is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -100.0% is the lowest of 6, against a peer median of +21.6%.
  • Interest expense amounts to 0.0% of revenue for OGI, versus a peer median of 5.7%.
OGI Competitors
Interest Expense for OGI and competitors
Company Period LTM YoY 3-year CAGR% of revenue
IVAInventiva S.A.FY2025€32.3M EUR+165.2%+257.5%720.4%
LFCRLifecore Biomedical, Inc.LTM Mar 2026$22.88M USD—+12.0%16.9%
ACBAurora Cannabis Inc.LTM Mar 2026CA$5.82M CAD-30.9%-64.2%1.9%
DERMJourney Medical CorporationLTM Mar 2026$3.7M USD+21.6%+22.4%5.7%
OBIOOrchestra BioMed Holdings, Inc.LTM Mar 2026$2.1M USD——6.4%
INFUInfuSystem Holdings, Inc.LTM Mar 2026$840K USD-49.3%-2.5%0.6%
HSDTSolana CompanyLTM Mar 2026$629K USD+6888.9%-8.7%6.6%
OGIOrganigram Global Inc.LTM Mar 2026CA$0 CAD-100.0%—0.0%
ELMDElectromed, Inc.LTM Mar 2026$0 USD——0.0%
RNACCartesian Therapeutics, Inc.LTM Mar 2026$0 USD——0.0%
Peer median (excluding OGI) —+21.6%+4.7%5.7%

Competitors are the stored peer set for OGI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

CAD
Metric
FY2021
Aug 2021
FY2022
Aug 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
Revenue79.16M145.81M149.21M159.84M186.09M
Cost of Revenue107.56M114.24M114.13M112.32M179.26M
Gross Profit(28.4M)31.57M35.07M47.52M6.83M
Gross Margin-35.9%21.7%23.5%29.7%3.7%
Research & Development3.45M5.96M12.19M11.2M10.95M
Selling, General & Admin46.47M59.21M71.68M68.14M86.88M
Operating Expenses63.42M74.72M271.48M83.2M70.24M
Depreciation & Amortization31.03M24.91M23.43M12.08M12.91M
EBITDA(96.71M)10.97M(25.37M)(23.59M)(14.76M)
EBITDA Margin-122.2%7.5%-17.0%-14.8%-7.9%
Operating Income(91.82M)(43.15M)(242.74M)(35.67M)(63.41M)
Operating Margin-116.0%-29.6%-162.7%-22.3%-34.1%
Interest Income003.69M0825.7K
Interest Expense2.96M429K277.85K00
Other Income / Expenses(38.88M)28.78M(184.21M)(9.77M)35.74M
Income Before Tax(130.7M)(14.37M)(233M)(45.44M)(27.66M)
Pre-Tax Margin-165.1%-9.9%-156.2%-28.4%-14.9%
Income Tax Expense0(88K)(3.52M)0(9.89M)
Net Income(130.7M)(14.28M)(229.48M)(45.44M)(17.78M)
Net Margin-165.1%-9.8%-153.8%-28.4%-9.6%
EPS (Basic)(2.04)(0.18)(2.82)(0.48)(0.14)
EPS (Diluted)(2.04)(0.18)(2.82)(0.48)(0.14)
Weighted Avg Shares64.03M80.01M81.29M95.29M127.67M
Weighted Avg Shares (Diluted)64.03M85.3M81.29M95.29M127.67M

Organigram Global Inc.

NASDAQ:OGI

Intrinsic Alpha fair value

Locked

Current Price

$0.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.